Stockscreener 앱 받기
84.84
1.00%
0.84
시장 영업 전:
84.85
0.010
+0.01%
Incyte Corp 주식(INCY)의 최신 뉴스
Long term hold vs stop loss in Incyte CorporationWeekly Trade Report & Safe Capital Growth Plans - Newser
Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership - Insider Monkey
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 27, 2025 - BioSpace
Can technical indicators confirm Incyte Corporation’s reversalJuly 2025 Trends & Target Return Focused Stock Picks - Newser
Chart based analysis of Incyte Corporation trends2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Incyte reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
How sentiment analysis helps forecast Incyte CorporationMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Quantitative breakdown of Incyte Corporation recent move2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Will breakout in Incyte Corporation lead to full recovery2025 Top Gainers & High Win Rate Trade Tips - Newser
Using RSI to spot recovery in Incyte CorporationMarket Trend Summary & Growth Focused Entry Reports - Newser
Will Incyte Corporation stock recover after recent dropQuarterly Investment Review & Safe Entry Momentum Tips - Newser
What institutional flow reveals about Incyte CorporationBull Run & Safe Capital Growth Plans - Newser
What Fibonacci levels say about Incyte Corporation reboundLayoff News & Safe Entry Zone Tips - Newser
Three Biotech Companies to Watch: Boston Scientific, Arcutis Biotherapeutics, and Incyte Corporation - AInvest
How institutional ownership impacts Incyte Corporation stockJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Will Incyte Corporation rebound enough to break evenJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
How to escape a deep drawdown in Incyte Corporation2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Incyte appoints Soni Basi as new chief human resources officer - Investing.com
Incyte Announces Executive Changes, Effective August 25, 2025 - MarketScreener
Incyte Corporation Company’s Quarterly Earnings Growth: What the Numbers SayQuarterly Profit Summary & Risk Controlled Daily Plans - Newser
Analyzing Incyte Corporation with risk reward ratio charts2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
How Incyte Corporation stock performs during market volatility2025 Major Catalysts & AI Optimized Trade Strategies - beatles.ru
Market Wrap: Is Incyte Corporation impacted by rising rates2025 Market Sentiment & Weekly High Momentum Picks - theviewers.co.kr
Apache, Incyte, Prudential, ON Semiconductor: 'Mad Money' Lightning Round - TheStreet
Incyte Corp. Stock Down Despite Market Surge - AInvest
JP Morgan Maintains Incyte (INCY) Rating, Raises Price Target to $73 | INCY Stock News - GuruFocus
JPMorgan Adjusts Price Target on Incyte to $73 From $67, Maintains Neutral Rating - MarketScreener
Incyte describes new MRGPRX2 antagonists - BioWorld MedTech
Are Wall Street Analysts Predicting Incyte Stock Will Climb or Sink? - MSN
INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold? - Yahoo Finance
Are Wall Street Analysts Predicting Incyte Stock Will Climb Or Sink? - Barchart.com
Using flow based indicators on Incyte CorporationQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Incyte to Present at Upcoming Investor Conferences - MarketScreener
Incyte Corp. stock underperforms Monday when compared to competitors - MarketWatch
Will Incyte Corporation Reverse From Oversold ConditionsJuly 2025 Intraday Action & Daily Risk Controlled Trade Plans - metrotimes.co.kr
Immuno-Oncology Stocks Q2 In Review: Incyte (NASDAQ:INCY) Vs Peers - Yahoo Finance
Incyte rises on results beat, lifted Jakafi guidance - MSN
Using portfolio simulators with Incyte Corporation included2025 Top Decliners & Risk Controlled Daily Plans - Newser
Incyte Corp (INCY) Set to Outperform Market: Strong Financial Growth and Competitive Advantage - AInvest
Cancer Stock Soars While This China Tech Stock Heads To New Highs - Investor's Business Daily
Incyte CFO Christiana Stamoulis to Step Down in September - MSN
Stock Analysis | Incyte OutlookMixed Signals Amid Rising Price and Strong Fundamentals - AInvest
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance
Incyte's 5.2% Surge on $270M Volume Ranks 430th Amid FDA Approval and Strategic Shifts - AInvest
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know - Yahoo Finance
Incyte stock hits 52-week high at 83.95 USD - Investing.com
The Top 5 Analyst Questions From Incyte’s Q2 Earnings Call - Yahoo Finance
Wells Fargo Upgrades Incyte Corporation (INCY) to Overweight From Equal Weight - Insider Monkey
Trapped Investors in Incyte Corporation Await Breakout SignalPortfolio Diversification Stock Ideas From Experts - beatles.ru
Incyte EVP Denton sells $45k in shares after option exercise - Investing.com Australia
Semerjian to lead Geron - BioCentury
0.98%
8.06%
자본화:
|
볼륨(24시간):